<span>In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the
Drugs and Money: Prices, Affordability and Cost Containment
โ Scribed by M. N. G. Dukes
- Publisher
- Published on Behalf of the World Health Organ
- Year
- 2003
- Tongue
- English
- Leaves
- 158
- Edition
- 7th
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Over the years, many countries have approached the World Health Organization for advice or information on the feasibility of measures to control the growth of expenditure on medicines. Such calls for help led the Organization to undertake a study as early as 1983. The report "Drugs and Money" was widely used and repeatedly updated. This edition aims to provide policy makers and regulators with a compact and practical review of the various approaches that have been developed and tested to date in an effort to contain the overall costs of pharmaceutical services and drug treatment. The true art of good housekeeping in this field is clearly to ensure that drugs continue to benefit society wherever they can, while eliminating every form of waste of public funds. The book also addresses issues of the organization, stands and delivery of health care. This volume devotes considerable attention to the special problems of developing countries and those where the economy is currently in transition.
๐ SIMILAR VOLUMES
<span>In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the
<span>In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the
<p><span>New Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points